MNPR

Monopar Therapeutics Inc

MNPR, USA

Monopar Therapeutics Inc., a clinical-stage biopharmaceutical company, engages in developing therapeutics for the treatment of cancer in the United States. The company develops ALXN1840, a late-stage, investigational once-daily and oral medicine; MNPR-101, a proprietary humanized monoclonal antibody that is conjugated with different radioisotopes for the treatment of advanced solid tumors expressing urokinase plasminogen activator receptor; and MNPR-101-Zr, a clinical-stage radiodiagnostic imaging agent comprised of MNPR-101 conjugated to zirconium-89. It develops MNPR-101-Lu, a late-preclinical stage radiotherapeutic comprised of MNPR-101 conjugated to actinium-225. The company has collaborations NorthStar to develop radio-immuno-therapeutics targeting severe COVID-19. The company was founded in 2014 and is headquartered in Wilmette, Illinois.

https://www.monopartx.com

Stock Price

$ 0.00

0% decrease compared to yesterday.

Dividend

Frequency:

N/A

Rate:

N/A

Next Payout:

N/A
MNPR
stock
MNPR

EKI Energy Services Limited Approaches Support With Recovery in Sight - Earnings Miss Alerts & Small Investment Wealth Growth earlytimes.in

Read more →
MNPR
stock
MNPR

How (MNPR) Movements Inform Risk Allocation Models news.stocktradersdaily.com

Read more →

Showing 2 of 10

Analyst Ratings & Sentiment

(Last Updated 2025-09-30)

Rating:

BUY

Target Price:

$111.7692

Analyst Picks

Strong Buy

2

Buy

2

Hold

1

Sell

0

Strong Sell

0

Sentiment:

Bullish

Finn Analysis

(Last Updated 2025-09-30)

Health Score

Price to Book Ratio (P/B)

-

Very High

3.80

Low ≤ 1

High ≥ 3

Return on Equity (ROE)

-

Very Low

-2.43 %

Low ≤ 5%

High ≥ 25%

Return on Assets (ROA)

-

Very Low

-2.38 %

Low ≤ 2%

High ≥ 10%

Debt to Equity

-

Very High

0.02

Low ≥ 1

High ≤ 0.3

Investors

* Institutions hold a combined 56.89% of the total shares of Monopar Therapeutics Inc

1.

HHG PLC

(19.0012%)

since

2025/06/30

2.

Adage Capital Partners Gp LLC

(9.7115%)

since

2025/06/30

3.

RA Capital Management, LLC

(8.2854%)

since

2025/06/30

4.

BlackRock Inc

(3.3253%)

since

2025/06/30

5.

Point72 Asset Management, L.P.

(1.6859%)

since

2025/06/30

6.

ADAR1 Capital Management LLC

(1.6365%)

since

2025/06/30

7.

Geode Capital Management, LLC

(1.5708%)

since

2025/06/30

8.

iShares Russell 2000 ETF

(1.5707%)

since

2025/08/31

9.

Vanguard Group Inc

(1.4018%)

since

2025/06/30

10.

Affinity Asset Advisors, LLC

(1.094%)

since

2025/06/30

11.

Vanguard Institutional Extnd Mkt Idx Tr

(0.7395%)

since

2025/07/31

12.

State Street Corp

(0.6779%)

since

2025/06/30

13.

Fidelity Small Cap Index

(0.662%)

since

2025/06/30

14.

iShares Russell 2000 Growth ETF

(0.6052%)

since

2025/08/31

15.

Ally Bridge Group (NY) LLC

(0.5598%)

since

2025/06/30

16.

Northern Trust Corp

(0.5156%)

since

2025/06/30

17.

Fidelity Extended Market Index

(0.3751%)

since

2025/07/31

18.

UBS Group AG

(0.3545%)

since

2025/06/30

19.

Vanguard Russell 2000 ETF

(0.3139%)

since

2025/07/31

20.

Millennium Management LLC

(0.2397%)

since

2025/06/30

21.

State St Russell Sm Cap® Indx SL Cl I

(0.2318%)

since

2025/08/31

22.

Charles Schwab Investment Management Inc

(0.2147%)

since

2025/06/30

23.

Schwab Small Cap Index

(0.1661%)

since

2025/07/31

24.

NT R2000 Index Fund - NL

(0.1594%)

since

2025/06/30

25.

iShares Micro-Cap ETF

(0.1494%)

since

2025/08/31

26.

Bank of New York Mellon Corp

(0.145%)

since

2025/06/30

27.

Susquehanna International Group, LLP

(0.1354%)

since

2025/06/30

28.

Fidelity Total Market Index

(0.1293%)

since

2025/07/31

29.

Morgan Stanley - Brokerage Accounts

(0.1286%)

since

2025/06/30

30.

NT R2000 Index Fund - DC - NL - 3

(0.1271%)

since

2025/06/30

31.

Barclays PLC

(0.1181%)

since

2025/06/30

32.

iShares Russell 2000 Small-Cap Idx Instl

(0.1141%)

since

2025/07/31

33.

Extended Equity Market Fund K

(0.111%)

since

2025/06/30

34.

Russell 2500â„¢ Index Fund F

(0.104%)

since

2025/06/30

35.

Citadel Advisors Llc

(0.101%)

since

2025/06/30

36.

Fidelity Series Total Market Index

(0.0982%)

since

2025/07/31

37.

Nuveen Small Cap Blend Idx R6

(0.0855%)

since

2025/07/31

38.

Spartan Extended Market Index Pool F

(0.0855%)

since

2025/07/31

39.

NT Ext Equity Mkt Idx Fd - L

(0.0817%)

since

2025/06/30

40.

Northern Trust Extended Eq Market Idx

(0.0817%)

since

2025/06/30

* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.

Earnings History

EPS ActualEPS EstimateEPS DifferenceSurprise Percent

Upcoming Earnings Release

Date

—

EPS Estimate

—

Latest Release

Date

2025-09-30

EPS Actual

-0.48

EPS Estimate

-0.3989

EPS Difference

-0.0811

Surprise Percent

-20.3309%

Investing Fit Scorecard

(Last Updated 2025-09-30)

Deep Value
Potential Value Candidate(3.5)
Defensive
Highly Defensive(7)
Dividend
Weak Dividend Profile(1.5)
Economic Moat
Some Competitive Advantage(3.8)
GARP
Not Attractive for GARP(2)
Growth
Weak Growth Prospect(0.5)
Momentum
No Momentum(2)
Net Net
Not Undervalued (Net-Net)(2.5)
Quality
Low Quality Business(2.5)
Value
Overpriced(3)

Income Statement

(Last Updated 2025-09-30)

Revenue

$ 0

Cost Of Revenue

$ 0

Gross Profit

$ 0

Operating Expenses

$ 0

Operating Income

$ 0

Interest Expense

$ 0

Pretax Income

$ 0

Net Income

$ 0

Income Tax Expense

$ 0

EBITDA

$ 0

Total Other Income Expense Net

$ 0

Earnings Per Share

0

Dividends Per Share

0

Shares Outstanding

0

Operating Margin

0%

Trend

Balance Sheet

(Last Updated 2025-09-30)

Cash

$ 0

Short Term Investments

$ 0

Receivables

$ 0

Inventories

$ 0

Total Current Assets

$ 0

Property Plant Equipment

$ 0

Total Assets

$ 0

Payables

$ 0

Short Term Debt

$ 0

Long Term Debt

$ 0

Total Liabilities

$ 0

Equity

$ 0

Trend

Cash Flow

(Last Updated 2025-09-30)

Net Income

$ 0

Depreciation

$ 0

Change In Working Capital

$ 0

Cash From Operations

$ 0

Capital Expenditures

$ 0

Cash From Investing

$ 0

Cash From Financing

$ 0

Net Change In Cash

$ 0

Trend

Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.